New study explores how lung nodule patients make tough treatment choices
NCT ID NCT07590596
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study looks at how adults with lung nodules that might be cancer make decisions about their care before a final diagnosis. Researchers will use questionnaires to measure patients' confidence, doubts, and satisfaction with their choices. The goal is to find out what factors help or hinder good decision-making, so doctors can better support patients in the future. No treatments or changes to care are involved.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify patients who need extra support when making decisions about lung nodule treatment.
- What could go wrong
- This is an observational study with no treatment given, so it cannot directly improve health outcomes. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREOPERATIVE DECISION-MAKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China
Chengdu, Sichuan, 610041, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Robot and 3D imaging join forces to spot lung cancer in HIV patients
- Quit smoking support during lung cancer tests boosts quit attempts
- Blood test may spot lung cancer sooner in High-Risk patients
- New pain block could speed recovery after lung surgery
- Glow-in-the-dark dye could help doctors spot lung cancer during a scope exam
- New biomarker model aims to reduce unnecessary lung biopsies